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Abstract
Retro-biosynthesis is a novel pathway design method that integrates biocatalysis (in
particular, functional group specificity and reactivity of enzymes) and organic chemistry.
Using this method, several novel pathways have been designed in this laboratory for the
microbial production of glucaric acid. In addition to design, efforts have been made in
order to express these pathways inside E. col. For the production of glucaric acid in E.
coil, toxicity of this organic acid as well as the uptake efficiency of glucose, the starting
substrate, when in the presence of glucaric acid was assessed. Furthermore, a benchmark
pathway for glucaric acid production that utilizes known reaction steps from different
source organisms was designed. The design and expression of this pathway will be
compared to the retro-biosynthetic pathway. The ease of design and expression will be
analyzed in order to confirm the validity of retro-biosynthesis.
Toxicity results showed that glucaric acid concentrations, up to 40 mM, do not affect
growth of E. coli DH1OB cells. Furthermore, cells take up equal amounts of glucose even
when glucaric acid is available, indicating that glucose is preferentially utilized by cells
and that glucaric acid, once produced by cells, would not affect further production.
Finally, efforts have been made in order to express the benchmark pathway in E. coli.
The entire pathway requires expression of three enzymes. The final reaction step requires
uronate dehydrogenase in order to convert glucuronic acid to the desired product,
glucaric acid. Although the function and approximate molecular weight of uronate
dehydrogenase is known, its DNA sequence is not. Isolating the gene encoding the
enzyme can be facilitated by a partial digestion of the genomic DNA of the source
organism, P. syringae. A screening method for uronate dehydrogenase activity has also
been developed and optimized. Using this screening method, the library was constructed
in E. coli. Once colonies that contain uronate dehydrogenase are selected, this enzyme's
sequence can be determined and the benchmark pathway can be closer to becoming
expressed.
Thesis Supervisor: Kristala Jones Prather
Title: Joseph R. Mares (1924) Assistant Professor of Chemical Engineering
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1. Introduction
As more organic compounds are synthesized and identified as beneficial, new
methods are being determined for their large scale and inexpensive production.
Specifically, and for the interest of our laboratory, new pathway design tools and
pathway expression/engineering (protein and metabolic engineering) techniques are being
used for the production of these organic compounds in E. coli.
Some pathway design methods include using metabolic network and enzyme
databases such as KEGG (I) and BRENDA (2), respectively. Computational tools that
utilize graph theory integrated with group contribution theory can also identify
alternative, thermodynamically favorable routes for the expression of a desired product
(3). Pathway expression techniques include enzyme evolution and directed mutagenesis,
gene/pathway insertion and deletion, as well as the modulation of enzyme expression or
substrate type and availability. Our laboratory is applying a new pathway design method,
retro-biosynthesis, in order to produce natural or un-natural organic compounds in E.
coli. Once designed, the pathway will then be expressed in this microorganism by
considering the many pathway engineering tools mentioned above.
This new design tool has the benefit of allowing one to control the starting
substrate, making sure E. coli can either utilize or make it in large-scale, inexpensive
quantities. Furthermore, unlike other pathway design methods, retro-biosynthesis is
systematic and requires every step to be tested and controlled. As a result, desired
products are made rather than random general structures like in previous pathway
engineering efforts (the microbial production of isoprenoids, 4). Pathways are designed in
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a more efficient and flexible manner as well. Enzymes are chosen for their functional
group specificity and conversion rather than substrate specificity.
Retro-biosynthesis integrates knowledge of enzyme function, organic chemistry,
and metabolism. Once a desired organic compound is identified, its structure is first
compared to a substrate E. coli can make and/or utilize. Then, enzymes are analyzed for
their ability to be selective towards functional groups and to perform the conversions
needed in order to generate the product. Once the biosynthetic pathway is constructed in
this way, expression optimization methods and viability considerations must be made in
order to express the pathway inside E. coil. Retro-biosynthesis will be used in order to
design a novel biosynthetic pathway for the microbial production of glucaric acid.
However, a benchmark pathway was first designed using enzyme and reaction databases
as discussed above.
1.1 The benchmark pathway
The benchmark pathway for the biosynthesis of glucaric acid was designed and
will be compared to the pathways proposed via retro-biosynthesis. It was designed in
order to express an already "proven" pathway inside E. coli and determine whether
glucaric acid can be produced. The pathway is proven because every reaction step is
known to occur even though all are not from the same source organism. While retro-
biosynthesis considers general enzyme function (at the functional group level), the
benchmark pathway considers specific enzyme reactions. Each step has already been
identified in individual organisms. The required enzymes and their functions are
displayed in enzyme/reaction databases. Step by step, they are retrieved and isolated from
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the organisms in which they function and assembled to produce the desired product:
glucaric acid.
Retro-biosynthetically derived pathways would consider enzymes' functional
group specificity instead. The reaction steps are not necessarily natural steps already
known to occur in organisms. Therefore, although easier to design, expressing the
pathway inside E. coli can be more of a challenge. Enzymes may need to be modified in
order to be substrate specific. Furthermore, new assays may need to be developed in
order to prove enzyme function as well as measure and quantify product formation in E.
coli.
The design method of retro-biosynthesis, and the work of having to
identify/modify unproven reaction steps, can be compared to expressing naturally
occurring reaction steps in E. coli by first expressing the benchmark pathway (Figure 1).
10
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Figure 1: Benchmark Pathway for Glucaric Acid
Each step is already known to occur in specific organisms and each enzyme is substrate
specific rather than functional group specific. The first three steps can occur by cloning
just one enzyme (EC 5.5.1.4, 5). Myo-inositol oxygenase, found in pig, rat, human, and
mouse, can convert myo-inositol to glucuronic acid (6). Uronate dehydrogenase,
reportedly from P. syringae, has been shown to convert glucuronic acid to glucaric acid
(7,8, ).
It may be possible to produce glucaric acid by expressing three already verified
enzymes, obtained from separate organisms, inside E. coli that is grown in glucose (the
starting substrate). The first three steps have already been demonstrated in E. coli ().
According to Hansen et al., myo-inositol can be produced by E. coli after isolating and
expressing myo-inositol 1-phosphate synthase from S. cerevisiae. Glucose is
phosphorylated to glucose-6-phosphate (using E. coli's phosphotransferase system and
phosphoenolypyruvate as the source of phosphate). Glucose-6-phosphate can be
converted to myo-inositol phosphate using myo-inositol 1-phosphate synthase. This
substrate can then be dephosphorylated and has been shown to do so by "unknown
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cytosolic or periplasmic phosphatase activity" (5). Then, myo-inositol oxygenase, found
in humans, mice, rats, and pigs, can be used in order to convert myo-inositol to
glucuronic acid (6). The final reaction step requires uronate dehydrogenase, which is
known to occur in P. syringae (7, 8, 9). Once this enzyme functions properly in E. coli
and has glucuronic acid as substrate via the other steps of the pathway, glucaric acid can
then be produced.
Many considerations must be made before the benchmark pathway can be
successfully expressed in E. coli. If product is available, toxicity and uptake efficiency
studies can be performed in order to determine whether producing the desired organic
compound will limit the cell's viability or the starting substrate's uptake, respectively.
Furthermore, an in vivo and/or in vitro assay would need to be prepared for each step in
order to prove, quantify, and ensure optimized conversion. Since each enzyme comes
from a different source organism, isolation and compatibility issues must be considered.
Substrates/products can be verified using previously known assays and/or structure
determination techniques like HPLC, NMR, or mass spectroscopy.
My work includes performing these toxicity and uptake efficiency studies in order
to determine whether glucaric acid affects cell viability and glucose uptake. Efforts have
also been made in order to complete the final step of the pathway - obtaining uronate
dehydrogenase, expressing it inside E. coli, and making sure glucaric acid is produced
when glucuronic acid is available.
For expression of the other reaction steps of the benchmark pathway inside E.
coil, the first two enzymes, myo-inositol 1-phosphate synthase and myo-inositol
oxygenase have already been isolated from their respective source organisms by another
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lab member. Methods for measuring glucuronic acid and myo-inositol have also been
identified (10 and 11, respectively).
1.2 Expressing the final reaction step of the benchmark pathway in E. coli
The final reaction step, as mentioned before, is the conversion of glucuronic acid
to the desired product, glucaric acid (Figure 2).
1 1
glucuronic acid dehydrogenase glucaric acid
NADI + H20 NADH + HI
Figure 2: Final Step of the Benchmark Pathway
Glucuronic acid is converted to glucaric acid (with reduction of NAD+ to NADH) by
uronate dehydrogenase.
According to the reaction, uronate dehydrogenase, NAD*, and glucuronic acid are
required for the production of glucaric acid (Figure 2). Since this reaction step occurs in
P. syringae, the goal was to isolate uronate dehydrogenase from this organism, test the
reaction in vitro, and express uronate dehydrogenase activity in E. coli.
First, an in vitro test was performed in order to confirm the presence of uronate
dehydrogenase in P. syringae DC3000. Secondly, a screening method was determined
and identified in order to be able to test uronate dehydrogenase's function in E. coli.
Finally, uronate dehydrogenase will be isolated and expressed in E. coli in order to
confirm it functions similarly in this strain.
13
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Specific considerations needed to be made for isolating uronate dehydrogenase
and testing its activity in vivo. Since the sequence of uronate dehydrogenase is not
known, it was not possible to isolate the gene using PCR amplification. Furthermore,
although the approximate size of the protein is known (reported to be 60 kilodaltons, 30
kd for each subunit, 7), it was not purified and sequenced. Instead, P. syringae cell
lysates were prepared and used in order to test for uronate dehydrogenase activity in
vitro. Then, once a screening method was identified for confirming the function of
uronate dehydrogenase in E. coli, a partial digestion of P. syringae genomic DNA was
performed and cloned into a plasmid. This library will be expressed in E. coli. The
screening method will then be used in order to test for uronate dehydrogenase activity in
E. coli (and to eventually isolate and sequence the gene). Once this enzyme is
successfully identified and its function is confirmed, the final reaction step of the
benchmark pathway will be complete.
The following includes procedures and current results for toxicity, uptake
efficiency, and expressing the final step of the pathway in E. coli. I will conclude by
discussing the future work necessary for completing expression of the benchmark
pathway. Eventually, the retro-biosynthetically designed glucaric acid pathways can be
expressed and compared to the benchmark pathway. The ease of retro-biosynthetic design
and feasibility of expression can then be assessed.
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2. Materials and Methods
2.1 Glucaric acid toxicity: specific growth rate determination for cells grown in
varying concentrations of glucaric acid
Specific growth rates for E. coli DH1OB cells were determined when grown in
increasing concentrations of glucaric acid. DH10B was grown in minimal media (M9
salts, 0.8 mM leucine, 0.1 mM CaC12, and 0.2 mM MgSO4, 12) supplemented with 22
mM glucose and increasing concentrations of glucaric acid. A 5X stock solution of M9
salts consists of 64 g Na2HPO5(7H20), 15 g KH2PO4, 2.5g NaCl, and 5.0 g NH4C1 in one
liter of deionized H20 (12). Glucaric acid concentrations of 0 mM, 10 mM, 22 mM, and
40 mM were tested, adjusting media to physiological pH (7.4) as needed. Cultures were
inoculated with 1% v/v of an overnight LB culture that reached an OD600 of 2.3. Cell
concentrations were measured at increasing time points. The specific growth rates for
cultures grown in varying amounts of glucaric acid were determined using a general, first
order rate expression for cell growth,
dX
dt
where X is the cell concentration (OD600o) during the exponential phase, and u is the
specific growth rate (hr-'). Upon integration, the following expression is obtained,
In X =_!(t-to )
X
where X is the initial cell concentration corresponding to the initial time point, to, of
the exponential phase. Accordingly, specific growth rates are the slopes when data points
are plotted on a semi-log plot.
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In order to determine the specific growth rates for E. coli DH1OB cells when
grown in increasing concentrations of glucaric acid, a growth curve was generated for
each case. Since the rate expression is valid for cells grown in exponential phase, growth
rate determination was based on data points from the exponential phase only (time points
between 7 to 12 hours, according to the growth curves obtained). The rate expression was
then evaluated for each of the four cell cultures in order to determine specific growth
rates and whether glucaric acid is toxic to cells.
2.2 Glucose uptake efficiency in the presence of glucaric acid
Cells were grown in minimal media (same concentrations of M9, CaC12, MgSO4,
and leucine as above) supplemented with 22 mM glucose and increasing concentrations
of glucaric acid (0 mM, 7.5 mM, and 15 mM). The media was adjusted to physiological
pH. After DH10OB cells were inoculated into 50 mL cultures, from a 2 mL LB overnight
culture (that had reached an OD600 of 1.3), 1 mL samples were removed at many time
points throughout growth. Each sample was centrifuged at 5,000 rpm for 5 min. The
supernatant was saved in the -200 C freezer until glucose concentration was measured.
Once the culture reached stationary phase and the final sample was obtained, a YSI
analyzer (YSI 2700 select) containing a glucose membrane (YSI 2365 glucose membrane
kit; Yellow Springs Instruments Co., Inc.), was used in order to measure glucose
concentrations for each time point. The membrane contains immobilized glucose oxidase,
which completely oxidizes D-glucose to hydrogen peroxide and D-gluconic acid. The
analyzer measures the amount of hydrogen peroxide produced, which reflects the
concentration of D-glucose.
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2.3 Preparing P. syringae lysate and testing for uronate dehydrogenase activity
P. syringae DC3000 was grown in a 25 mL solution of LB and 50 ug/mL of
Rifampicin (shaken/incubated at room temperature). At an OD600 of 1.1, 0.1% v/v of cell
culture was inoculated into a 25 mL minimal media solution (M9 salts, 0.1 mM CaC12,
0.2 mM MgSO 4, and 50 ug/mL of Rifampicin) supplemented with 22 mM glucose. After
44 hours of growth, an OD600 of 1.9 was reached and 0.1% v/v of this culture was
inoculated into 25 mL of minimal media either supplemented with 22 mM glucose or
glucuronic acid. At stationary phase, equal concentrations of cells were lysed in order to
isolate comparable concentrations of protein. Before cells were lysed, each culture had an
OD600 of 1.75. This was achieved by diluting cells grown in glucuronic acid, which
reached an OD600 of 1.84, with minimal media (without antibiotic or carbon source).
Protein extracts were obtained using lysozyme and freeze/thaw cycles in liquid N2
and 370C water. A volume of 1 mL of equal concentrations of cell culture (P. syringae
grown in glucose and glucuronic acid) was centrifuged at 5,000 rpm for 5 min (at 40C).
Pellets were resuspended in 100 uL of Phosphate Buffered Saline solution (1.37 mM
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 2 mM KH2PO4, 13) and 1 mg/ml lysozyme.
The tubes were then incubated in ice for 30 min. Five freeze/thaw cycles were performed
with liquid N2 and 370C water. Once these cycles were complete, the samples were
centrifuged at 14,000 rpm for 10 min (at 40C). The supernatant was stored at -200 C until
the reaction was performed.
These extracts were then reacted with glucuronic acid and NAD+. NADH
concentrations were then determined by measuring absorbance at 340 nm. Equal protein
concentrations were desired for this in vitro assay. The Bradford assay (14) was used in
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order to measure protein concentrations. A concentrated Protein Assay reagent was
purchased from Bio-Rad (Hercules, CA) and used according to manufacturer's protocol.
First, a standard curve was obtained by measuring absorbances of known concentrations
of BSA solution. The OD595 corresponding to BSA concentrations of 0, 0.2, 0.4, 0.6, 0.8,
and 1.0 mg/mL were measured. A plot of absorbance vs. protein concentration was
generated and a line of best fit was identified.
Protein concentrations of 0.76 mg/mL and 0.68 mg/mL were obtained from cells
grown in glucose and glucuronic acid, respectively. These cell extracts were not adjusted
to have equal protein concentrations. Simulating the procedure performed by Wagner et
al. (7), a 0.05 M Na2HPO4, 0.33 mM glucuronic acid, and 1 uM NAD+ solution was
prepared for the reaction. 500 uL of this solution was transferred to a quartz cuvette in
order to blank at 340 nm. 1/30th volume of protein was then added to the substrate
mixture and absorbance was measured every 30 sec (for 10 min) in order to detect
increasing concentrations of NADH. The concentration of NADH was determined for
each time point using the Beer-Lambert Law:
A = * C * I
where A is the absorbance (measured at 340 nm), is the extinction coefficient (which
is a known value for NADH at 340 nm), C is the concentration of NADH (in mmol/L),
and I is the path length (dependent on the size of cuvette used). The extinction
coefficient of NADH, at 340 nm, is 6.22 L/(mmol*cm) (9) and the path length is 1 cm.
The expression was evaluated in order to determine NADH concentration that
corresponds to the absorbance measurements with time.
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2.4 Optimizing screening method
BL21(DE3) was tested in liquid for its ability to grow in glucaric acid or
glucuronic acid. Cells were grown in minimal media solution supplemented with 22 mM
glucose. 0.1% v/v of a culture that reached an OD600 of 2.5 (and then diluted to 0.4 using
minimal media solution without carbon source) was added to a 25 mL solution of
minimal media either supplemented with 22 mM glucose, glucaric acid, or glucuronic
acid.
DH1OB was also tested in liquid as well as on minimal media plates
supplemented with glucose, glucaric acid, or glucuronic acid. Cells were grown in a 25
mL solution of minimal media (M9 salts, 0.8 mM Leucine, 0.1 mM CaCL 2, and 0.2 mM
MgSO 4) supplemented with 22 mM glucose. 0.1% v/v of a culture that had reached an
OD600 of 2.3 was then inoculated into a 25 mL minimal media solution supplemented
with 22 mM glucose, glucaric acid, or glucuronic acid (and pH adjusted as needed). Cells
were plated as well. 100 uL of a 20% v/v solution of cell culture (that was at an OD600 of
2.3) in water was spread on plates that contained minimal media supplemented with 22
mM glucose, glucaric acid, or glucuronic acid. All liquid and plates were incubated at
370C. Liquid flasks were shaken at 200 rpm.
DH5alpha and MG1655 cells were tested and compared to the results obtained
from BL21 (DE3) and DH1OB. Cells were grown in minimal media supplemented with 22
mM glucose. DH5alpha required 0.296 mM addition of thiamine in the minimal media
solution. For DH5alpha, 0.1% v/v of a culture that reached an OD600 0.91 was added to a
25 mL solution of minimal media (with 0.296 mM thiamine) supplemented with 22 mM
glucose, glucaric acid, or glucuronic acid. For MG1655, 0.1% v/v of a culture that
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reached an OD600 of 3.4 was added to a 25 mL solution with each of the organic acids as
well. Cell concentrations were measured with time.
DH10B-pGEM3Z cells were grown in a 25 mL solution of minimal media
supplemented with 22 mM glucose and 100 ug/mL of Ampicillin. 0.1% v/v of a culture
that reached an OD600 of 0.91 was added to a 25 mL solution of minimal media
supplemented with 22 mM glucose, glucaric acid, or glucuronic acid (and 100 ug/mL of
Ampicillin). Cell concentration was measured with time. Cells were also grown on plates.
100 uL of a 20% solution of cells (those that reached an OD600 of 0.91) was spread on
plates containing minimal media supplemented with 22 mM glucose, glucaric acid, and
glucuronic acid.
2.5 Testing screening method for DH1OB-pGEM3Z and DH1OB-pBluescript using
SOC transfer method
DH1OB was transformed with either pGEM3Z or pBluescript using
electroporation. Then, after a one hour incubation in SOC at 37C, cells were spread on
minimal media plates supplemented with 22 mM glucose used as a positive control,
glucaric acid, or glucuronic acid (with 100 ug/mL Ampicillin and 0.1 mM IPTG).
Transformations were diluted in LB to obtain about 100 colonies on plates (100 X 15mm
Petri dishes).
2.6 Isolating genomic DNA of P. syringae DC3000 for partial digestion
P. syringae was grown in a 25 mL solution of LB and 50 ug/mL of Rifampicin.
The Wizard Genomic DNA Purification Kit for gram-negative bacteria (Promega,
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Madison, WI) was used in order to isolate the genomic DNA from 2 mL of cells that had
reached an OD600 of 1.9. A total volume of 400 uL of genomic DNA was obtained. The
concentration of DNA was measured in order to determine the amount needed for the
partial digestion. The absorbance of isolated genomic DNA, measured at 260 nm, was
31.1. It is known that an absorbance of 1 corresponds to a concentration of 50 ug/mL
(15). Therefore, the absorbance obtained at 260 nm corresponds to a DNA concentration
of 1,555 ug/mL. Furthermore, the OD260:OD280o was determined to be close to 2 (1.98)
indicating a pure DNA solution. An equal volume of DNA rehydration solution was
added in order to dilute this sample. A concentration of 777.5 ug/mL was obtained at a
total volume of 800 uL.
2.7 Genomic DNA library construction
For the vector, pBluescript was isolated and digested with BamH1. A 65 ug/mL
concentration of pBluescript was obtained. The digestion consisted of 3.64 ug of plasmid,
140 units of BamH1, and 10X BamHl buffer. The final volume was 70 uL and this was
incubated at 370C for 3.5 hrs. The digest was run on a gel and purified to a concentration
of 80 ug/mL (30 uL total volume). Alkaline phosphatase was then used in order to
prevent vector re-ligation. For the dephosphorylation reaction, 2.088 ug of this newly
digested plasmid was used with 9 units of Calf Intestinal Alkaline Phoshatase. This
solution was incubated for 1 hr at 370 C and the DNA was purified using Qiagen's PCR
purification kit (Qiagen, Inc., Valencia, CA). The final digested and dephosphorylated
vector concentration was 45 ug/mL at a final volume of 30 uL.
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In order to obtain the inserts that will hopefully carry uronate dehydrogenase, a
partial digestion of the genomic DNA of P. syringae was performed. First, inserts within
a 1-5 kb range were obtained and tested. These fragments were from several partial
digestions. The conditions used for the partial digestions included 40 ug of DNA, 1OX
Sau3Al buffer, varying concentrations of Sau3A1 enzyme in order to optimize, and
enough ddH2O in order to reach a final volume of 100 uL. The digest was incubated at
370C for 2.5 hours. The 1-5 kb range was cut from the gel and purified. Enzyme quantity
ranged from 1.5 to 2 units. All partial digestions were run on a gel (about 2 ug of each)
and a 1-5 kb fragment range was excised from each and purified to 50 uL. All purified
fragments were combined and used as insert. The purified product (1-5 kb range of
fragments) was 15 ug/mL. The ligation reaction that resulted in the most successful
clones consisted of 0.045 ug of digested, dephosphorylated vector, 0.06 ug of insert, 10X
T4 ligase or 400 units (New England Biolabs, Beverly, MA), O1X T4 ligase buffer (New
England Biolabs, Beverly, MA), and enough ddH2O in order to reach a final ligation
volume of 10 uL. This reaction was left at room temperature for 12 hrs before it was used
for transforming DH1OB cells. Cells were electroporated (1 uL of ligation into 20 uL of
electrocompetent DH1OB cells) and after a one hour incubation in SOC at 370C, the
entire transformation was spread on a single plate containing LB, 100 ug/mL Ampicillin,
0.1 mM IPTG, and 0.04g/L ready-to-use X-gal.
The volume size of the ligation reaction was increased in order to optimize library
size. Using the same mass of DNA (insert and vector) and equivalent concentrations for
ligase and ligase buffer, the total volume was increased to 25 uL, 50 uL, and 75 uL.
These ligations were incubated at 160C for ten hours. Ethanol precipitation (16) was then
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performed in order to reduce the volume back down to 10 uL. The procedure includes
adding 1/10 ligation volume of 3 M sodium acetate (at pH 5.5) and 1/100 ligation volume
of 1% stock solution of blue dextran (1 g of blue dextran per 100 mL of water). After
leaving 100% ethanol inside the -800C freezer for five minutes, 2.5 times the ligation
volume of this was added to the solution. This was centrifuged at 13,200 rpm for 15 min
at 40C. The supernatant was discarded using aspiration, and 50 uL of 70% ethanol was
added to the pellet in order to wash. This was then centrifuged at 13,200 rpm for 3 min at
4°C. Finally, once the supernatant was removed via aspiration and all ethanol had been
evaporated at room temperature or 370C for 5-10 min, 10 uL of ddH20 was added. This
was then left in the 40C refrigerator overnight.
DH1OB cells were transformed, using these ligations, in a similar fashion as
above. The entire transformation was then plated on LB, 100 ug/mL Ampicillin, 0.1 mM
IPTG, and 0.04g/L ready-to-use X-gal.
For further optimization, whole partial digestions were purified using Qiagen's
PCR purification method instead of excising size-selected bands and purifying them from
a gel. For partial digestions, 40 ug of genomic DNA was used as before. The amount of
enzyme was varied in order to try to optimize the size of fragments from the partial
digestion. Four partial digestions were performed, using 1, 1.25, 1.5, and 2 units of
Sau3A1. A 10X concentration of Sau3A1 buffer and enough volume to reach 100 uL for
each reaction was used. The digests were incubated at 370C for 2.5 hrs. Each partial
digest was purified and eluted from the Qiagen column with 35 uL elution buffer. 10 ug
was run on a gel to analyze the reactions. All four digests were combined to a total
volume of 140 uL and concentration of 175 ug/mL.
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The inserts were ligated with the original, BamH1-digested and dephosphorylated
pBluescript vector. The optimal ligation, resulting in the most number of clones,
consisted of 0.045 ug of digested, dephosphorylated vector, 0.35 ug of insert, 400 units of
T4 ligase, 10OX T4 ligase buffer, and enough water to reach 10 uL. This reaction was left
at 160C for 9 hrs before DH1OB cells were transformed. The entire transformation (20 uL
of electrocompetent DH1OB cells were transformed with 1 uL of ligation as before) was
incubated in SOC for 1 hr at 370C then spread on a single plate that contained LB, 100
ug/mL Ampicillin, 0.1 mM IPTG, and 0.04g/L ready-to-use X-gal.
In order to determine the size of fragments that resulted in successful clones (to
confirm the "real" library size), twenty white colonies were miniprepped and digested in
order to check for insert. A blue, insert-less colony was also miniprepped and digested as
control. Each colony was grown in a 2 mL solution of LB and 100 ug/mL of Ampicillin.
Plasmids were then isolated from 1 mL cultures and eluted to 50 uL. Each plasmid was
then digested with HindIII in order to determine the size of the inserts. The fragments are
not able to be completely isolated since all cut sites are located at one end of these inserts.
However, since the size of pBluescript is known (3 kb in length), the fragment size can be
determined using a single digest. Each digestion reaction contained 20% v/v plasmid, 40
units of HindIII, 10X Buffer 2, and enough ddH20 to reach a total volume of 25 uL. They
were incubated at 370C for 2.5 hrs.
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3. Results and Discussion
3.1 Glucaric acid toxicity
A viable cell is required for glucaric acid production. Once the pathway is
expressed and glucaric acid is generated (and released from the cell), understanding
whether it affects a cell's growth is important for maximizing further production of the
desired organic compound.
The specific growth rate defines the rate of cell production. Therefore, similar
specific growth rates at each glucaric acid concentration would indicate an equal rate of
production of DH1OB cells at all concentrations tested. As a result, once this pathway is
expressed in E. coli and the organic acid is produced, the cells' growth, and, therefore,
glucaric acid production, would not be affected.
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Figure 3: Growth Curve and Specific Growth Rate Determination for DH1OB Cells
in Glucaric Acid
(A) E. coli DH1OB cells were grown in minimal media supplemented with 22 mM
glucose and increasing concentrations of glucaric acid (pH adjusted). (B) Specific growth
rates were only considered at exponential phase (data points were taken from 7 to 12 hrs).
Specific growth rates (the slope of each line) were 0.46, 0.43, 0.42, and 0.42 (hr' ')
for cultures grown in glucaric acid concentrations of 0 mM, 10 mM, 22 mM, and 40 mM,
respectively (Figure 3B). Since these values are similar, glucaric acid, up to 40 mM
tested, does not affect the growth of cells.
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Toxicity studies confirmed that cells will remain viable when glucaric acid is
produced. Uptake efficiency studies would indicate whether glucaric acid would affect
the amount of glucose that can be transported (and, therefore, utilized) inside cells. The
goal is to maximize the amount of glucose cells can utilize for energy, for other cellular
processes, and for making glucaric acid (since glucose is the starting substrate for the
benchmark pathway). Therefore, it is necessary to be confident that glucaric acid
production, once the pathway is expressed inside cells, will not affect glucose uptake or
utilization. This can be achieved by growing cells in glucose and varying concentrations
of glucaric acid. As the cells grew, the amount of glucose still in the media was measured
as a function of time. The addition of glucaric acid in the media did not affect glucose
uptake since glucose concentrations (in g/L) were very close to equal at all glucaric acid
concentrations for each time point (Figure 4).
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Figure 4: Uptake Efficiency of Glucose in the Presence of Glucaric Acid
(A) Growth curve and (B) corresponding measurements of glucose concentration in the
supernatant at specific time points.
For the growth curve, specific growth rates were calculated as before. The
exponential phase was taken to be between 6 and 11.5 hrs. Specific growth rates for each
culture were 0.56, 0.54, and 0.54 (hf 1) for cells grown in 22 mM glucose and 0 mM, 7.5
mM, and 15 mM, respectively. The fact that specific growth rates were similar at
increasing concentrations of glucaric acid confirms the E. coli DH1OB toxicity results.
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3.2 Testing P. syringae DC3000 for uronate dehydrogenase activity in vitro
After product considerations, efforts can now be made in order to express each
reaction step of the benchmark pathway in E. coli. The function of uronate
dehydrogenase was tested in vitro in order to confirm its presence in P. syringae as well
as its ability to convert glucuronic acid to glucaric acid. This was possible because of the
ability to repress or activate expression depending on the carbon source used. It is known
that in P. syringae, glucose inhibits uronate dehydrogenase expression. However,
glucuronic acid stimulates it (8). Once cells grow in glucose or glucuronic acid, their
protein can then be isolated and reacted with glucuronic acid and NAD+. The amount of
product can then be measured as an indication of whether uronate dehydrogenase is
available or not. Since glucaric acid assays using the HPLC are in development, the
enzyme's function was indirectly measured by determining the concentration of NADH.
Cells expressing uronate dehydrogenase, those that were grown in glucuronic acid,
should show an increase in NADH production due to this enzyme's ability to reduce
NAD+. Conversely, low NADH concentration is expected for cells grown in glucose.
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Figure 5: Measuring Uronate Dehydrogenase Activity
Slope is mmole of NADH/(L*min). The Beer-Lambert Law was used with an extinction
coefficient of 6.22 L/(mmol*cm) and a path length of 1 cm.
The specific activities for protein extracts obtained from P. syringae grown in
glucose and glucuronic acid were 0.1 U/g of protein and 26.4 U/g of protein, respectively.
In this case, units (U) represents the amount of NADH produced (mmol) per unit time
(min) in a total reaction volume of 500uL. Therefore, there is a significant increase in
NADH production with protein extracts obtained from cells grown in glucuronic acid.
Since it was reported that uronate dehydrogenase expression is stimulated with
glucuronic acid and repressed when cells are grown in glucose, it is apparent the increase
in NADH concentration via oxidiation of glucuronic acid is due to the presence of
uronate dehydrogenase in P. syringae. Future work will include using the HPLC (and a
boronic acid gel in order to isolate glucaric acid from other organic acids, 17) in order to
measure glucaric acid concentration. This will be invaluable for both proving uronate
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dehydrogenase activity in P. syringae as well as measuring glucaric acid produced once
the entire biosynthetic pathway is expressed in E. coli.
From previous articles concerning purification of uronate dehydrogenase and the
increase in NADH concentration when the expression of this enzyme is activated (7, 8,
9), it is evident that uronate dehydrogenase functions as shown and can be found in P.
syringae. Now, steps can be performed in order identify a screening method that can be
used in order to confirm uronate dehydrogenase's activity in E. coli.
3.3 Screening method for detecting uronate dehydrogenase activity in E. coli
If E. coli is unable, or just takes a very long time, to grow in glucuronic acid but
can grow well in glucaric acid, this would offer a way to screen for cells that contain
uronate dehydrogenase activity. This enzyme converts glucuronic acid to glucaric acid.
As a result, E. coli containing uronate dehydrogenase would be able to grow in
glucuronic acid since it would have the ability to make glucaric acid. Colonies that grow
on both glucuronic acid and glucaric acid plates would therefore contain fragments,
obtained from the partial digestion of the genomic DNA of P. syringae, that have uronate
dehydrogenase activity.
Specifically, fragments that were obtained from the genomic DNA of P. syringae
will be cloned into a vector and expressed in E. coli. Those cells that grow in glucuronic
acid would be selected for since they would have a high probability of containing uronate
dehydrogenase activity. The next step would be to purify protein after overexpressing
these DNA fragments. Then, using similar in vitro tests as described above, NADH
would be measured and compared to E. coli without P. syringae DNA fragments, as a
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negative control, at 340 nm. Glucaric acid measurements would also need to be made
once the HPLC procedure is developed. The screening method is dependent upon E.
coli's ability to grow in glucaric acid and not in glucuronic acid. The strain also depends
on the vector that is chosen for the library.
It was preferred that a vector containing two promoters of opposite direction on
either side of the multiple cloning site be chosen. That way, genes can be expressed from
a plasmid-based promoter regardless of what direction they are placed inside the vector
(especially important since inserts are obtained from a partial digestion of the entire
genomic DNA and only one enzyme/cut site is used). The vector pGEM3Z was chosen
because of this quality. It contains a T7 (up) and SP6 (down) promoter. However, in
order to use both promoters, an E. coli strain with both the T7 and SP6 RNA polymerase
had to be obtained. No strains were found with this capability. Therefore, the E. coli
strain BL21(DE3) was used for its ability to use the T7 promoter. The lac promoter,
which is in the opposite direction, was also available on the vector. Both promoters can
be used (lac promoter, upon induction with IPTG as well as T7 since strain includes the
T7 RNA polymerase) and there would be blue/white selection. Cell concentration as a
function of carbon source was measured with time. However, results showed that
BL21(DE3) does not grow in glucaric acid but does grow in glucuronic acid (Table 1).
Because of this, BL21 (DE3) cannot be used in order to test the library. The proposed
screening method is not compatible with this strain.
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Table 1: Growth of BL21(DE3) in Liquid Media Containing Organic Acids
BL21 (DE3) liquid results in 22 mM glucose, glucaric acid, and glucuronic acid. No cell
growth was apparent in glucaric acid. However, cells did grow in glucuronic acid.
Table 2: Growth of E. coli DH1OB in Liquid and on Solid Media Containing
Organic Acids
Liquid and Plate results for DH1OB grown in 22 mM glucose, glucaric acid, and
glucuronic acid.
E. coli DH1OB cells were tested as well. Cells were grown in minimal media
supplemented with glucose, glucaric acid, and glucuronic acid. Cells were also spread on
plates containing these organic acids. DH1OB liquid results show that these cells can
grow in glucaric acid, after 53 hrs, but not in glucuronic acid. Furthermore, colonies
appear on glucaric acid plates, after 60 hrs in this case, but not on plates supplemented
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with glucuronic acid (Table 2). Therefore, the proposed screening method seems as
though it would work with these cells. The next steps would be to confirm that cells
containing pGEM3Z act similarly in glucose, glucaric acid, and glucuronic acid as above,
and, finally, ligate fragments in the vector, express fragments in cells, and select for
colonies that grow on glucuronic acid.
The difference in growth between BL21(DE3) and DH1OB may be due to a
genetic difference in strains. Because of this great difference in E. coli strain growth in
liquid cultures, it was interesting to test other strains, like MG1655 and DH5alpha, in
order to determine what strains show similar results with DH1OB. Furthermore, if a
different strain is found to grow in glucaric acid but not glucuronic acid or in glucaric
acid at a faster rate, this may be more advantageous when the library is screened
(although it would not be possible to use the T7 promoter in either case). Faster growth in
glucaric acid would assume faster growth in glucuronic acid with uronate dehydrogenase,
depending on the rate of conversion from glucuronic acid to glucaric acid. This would
result in a faster observation of colonies containing uronate dehydrogenase activity.
34
DHSapha Reslts
Table 3: Growth of DH5alpha and MG1655 in Liquid Media Containing Organic
Acids
DH5alpha grew in glucuronic acid but not in glucaric acid during the time cells were
measured. MG1655 grew both in glucaric acid as well as in glucuronic acid.
DHSalpha grew in glucuronic acid but not in glucaric acid (Table 3). However,
since cell concentrations were not measured at longer times, it is not evident whether the
cultures just needed more time. MG1655, however, was able to grow both in glucaric
acid as well as in glucuronic acid within the time that was measured. Due to growth in
glucuronic acid, neither strain can be used for the library. Therefore, it is necessary to
revert back to DH1OB.
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Table 4: Growth of DH10OB-pGEM3Z in Liquid and on Solid Media Containing
Organic Acids
Comparing Table 4 to Table 2, although different starting cell concentrations were used,
it seems the vector causes cells to grow slower in liquid and to not grow at all on plates
when supplemented with 22 mM glucaric acid.
DH1OB containing pGEM3Z was tested for growth on the organic acids. This
strain, containing the plasmid of choice for the library, was tested both in liquid and on
plates in order to ensure similar results to DH1OB without plasmid. DH1OB-pGEM3Z
was not able to grow on plates supplemented with either glucaric acid or glucuronic acid
(Table 4). Furthermore, comparing liquid results of Table 4 to Table 2, although at
different starting cell concentrations, it seems pGEM3Z caused cells to grow slower in
glucaric acid. As expected, cells did not grow in glucuronic acid though. Since DH1OB-
pGEM3Z was not able to grow in glucaric acid, pGEM3Z cannot be the vector of choice
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for the library. The lack of growth in glucaric acid may be due to the high copy number
of pGEM3Z, possibly resulting in a metabolic burden. Instead, a lower copy number
plasmid, pBluescript, was tested both in liquid and on plates. Furthermore, a new method
of transfer (from liquid to plates and spreading technique) was used in order to ensure it
was not the method but the type of vector that caused the changes that were seen.
This time, a procedure was used that simulated how the actual library would be
tested. Once fragments obtained from the partial digest of P. syringae are ligated into the
vector of choice and library size has been optimized, E. coli would then be transformed
with these newly constructed, insert-containing, plasmids. Once transformed, cells would
then be spread on minimal media plates supplemented with either glucaric acid or
glucuronic acid. Therefore, whole plasmids (without fragments) were tested this way.
For purposes of determining whether the colonies grow on glucaric acid plates
and not on glucuronic acid as well as ensuring that equal numbers of colonies grow on
glucose and glucaric acid, efforts were made in order to have a countable number of
colonies on each plate. Furthermore, colonies were spread out in order to ensure that
neighboring cells will not affect how cells grow on their respective plates.
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Table 5: Growth of DH1OB-pGEM3Z and DH1OB-pBluescript on Solid Media
Containing Organic Acids
Cells containing pBluescript grew well on glucaric acid. The small colonies that grew on
glucuronic acid are not an issue considering how small they were even after 90 hrs. It
may merely be cells that grew in the LB media transformations were diluted with before
plating.
The method of transfer and plating may or may not have affected how cells grew
according to plate results seen in Table 4. There were 60 DH1OB-pGEM3Z colonies on
glucaric acid plates after 120 hrs (Table 5). However, the small colonies can either be due
to the length of time in incubation (plate conditions may have changed after so long) or
poor growth due to the vector used. DH1OB-pBluescript grew well on glucaric acid using
this method. However, small colonies were present on glucuronic acid as well. This will
be overlooked due to the length of time it took these colonies to grow and the possibility
that these cells grew merely from the LB the transformations were diluted and spread
with. Comparing DH1OB-pBluescript on glucose and glucaric acid plates, equal colonies
grew on glucose and glucaric acid. Furthermore, a similar number of colonies were
present on LB and glucose plates (76 and 86 colonies, respectively). This ensures that a
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maximum number of colonies can grow on minimal media plates. This is advantageous
since this amount would reflect the amount of colonies that would be tested on glucuronic
acid when the library is finally expressed.
Since DHlOB-pBluescript, and the method used to transfer and plate cells,
appeared to work well, it was not worth determining the cause for the results seen with
DH1OB-pGEM3Z. The strain that will be used is DH1OB. The vector of choice for my
library is pBluescript. Now, the library can be constructed and expressed in DH1OB.
Then, those colonies that grow on glucuronic acid plates would be selected as having
fragments with uronate dehydrogenase activity.
3.4 Genomic DNA library construction (cloning uronate dehydrogenase)
In order to isolate uronate dehydrogenase, a partial digest of the genomic DNA of
P. syringae was performed. The goal is to clone these fragments into pBluescript and
then express them in E. coli DH01B. Finally, using the proposed screening method
already discussed, select for colonies that exhibit uronate dehydrogenase activity.
BamH1 was used in order to digest pBluescript. For inserts, the genomic DNA of
P. syringae DC3000 was isolated and a partial digestion was performed. The Sau3A1
enzyme, which has a four base pair recognition site, was used (rather than a 6 base pair
site) in order to maximize the number of cuts that can be made. This site is compatible
with the BamH1 site and since pBluescript contains this restriction site, Sau3Al can be
used. Partial digestion would then result in a wide range of fragment sizes and a larger
number of fragments that may carry uronate dehydrogenase activity. The optimal
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condition would result in a partial digest that gives the most fragments that are within the
target gene's size range.
In order to ensure this range of fragments is obtained, partial digestions were run
on a gel and a 1-5 kb range was excised and gel-purified. Uronate dehydrogenase is
estimated to be about 1,300 bp, based on the molecular weight of the protein. Figure 6 is
a gel that includes two partial digests (left side of ladder). Lane 1 is from a partial digest
that includes 0.5 units of Sau3A1. The second lane contains 0.75 units of enzyme. A 1-5
kb piece of gel that was cut out from the partial digest that contained 0.75 units of
enzyme is also shown as an example (each partial digest contained 40 ug of DNA,
10XSau3A1 buffer, enough ddH20 to reach 100 uL once varying amounts of Sau3Al
was added, and incubated at 370C for 2.5 hrs).
I~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Figure 6: Excision of a 1-5kb Range of Fragments from a Partial Digestion of the
Genomic DNA of P. syringae
Partial digest of the genomic DNA of P. syringae at two different digestion conditions.
Lane 1: 2ug of a partial digest containing 40ug of DNA, 0.5 units of Sau3Al, and
incubated for 2.5 hrs at 370C. Lane 2: similar conditions but with 0.75 units of Sau3A1
instead. Lane 4: same as lane 2. The 1-5 kb range of fragments was cut from the gel in
order to show as an example. Lane 3 contains 0.25 ug of a 1.0 kb DNA ladder (New
England Biolabs, Beverly, MA).
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The partial digests resulted in fragment sizes that covered a range between -0.1
kb and -15 kb (Figure 6). Instead of considering the entire range of fragments, a 1-5 kb
range of digest was cut out of the gel and purified. Isolating this range will limit those
fragments that are of impractical size (either too small or too large to be uronate
dehydrogenase). However, it is important to note that fragments too large still have the
opportunity of expressing uronate dehydrogenase, either from its own promoter, or the
gene of interest may be within expression limits according to the vector's promoter and
strain's RNA polymerase.
As mentioned in the Materials and Methods section, several partial digests were
actually performed, containing enzyme concentrations from 1.5 to 2.0 units (Figure not
shown). Partial digests were run on a gel and a 1-5 kb range was cut from each lane
similar to how it is shown in Figure 6. Each excised gel was purified and combined. Now
that the inserts and vector (digested pBluescript) are available, a ligation reaction was
performed, DH1OB was transformed (via electroporation), and the library size was
counted.
If uronate dehydrogenase is estimated to be 1,300 bp (assumed from the measured
protein size), the number of clones required in order to obtain the gene inside fragments
of this exact length can be determined. Although, due to my partial digestion, there is a
wide range of fragments, this estimation can still be used in order to set the required
library size. The following equation can be used in order to determine the number of
clones needed (18).
ln(1- P)
ln(1 - f)
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From the equation, N is the number of clones needed, P is the desired probability that
the sequence will be represented (in the clone), and f is the ratio of gene size to the size
of the chromosome. The genomic DNA of P. syringae DC3000 was used for my partial
digestion. The size of this strain's chromosome is about 6.4 million base pairs. If the
desired probability is 99% and all the fragments were about 1,300 bp, a library size of
about 22,700 would be needed.
In a total of 100 colonies, half contained clones while the other half were insert-
less vector even when alkaline phosphatase was added. Attempts were made to increase
the library size by diluting the ligation and then concentrating this down to 10 uL using
ethanol precipitation. Diluting the ligation may result in more successful clones since
inserts would have more room to ligate with vector. Then, after the reaction is
concentrated in order to regain high DNA concentration, cells would be transformed and
the number of clones would be identified. After size is optimized by varying dilution, the
total volume would be increased and concentrated in order to transform cells with even
more DNA. This way, the transformation will be more efficient and more cells would
contain clones. However, results showed that the dilution step was not successful.
Plate results showed no improvement to the number of colonies. There were about
100 colonies per transformation on each plate. Half were successful clones while the
other half were insert-less vector. A ligation that results in 50 successful clones would not
be able to reach needed library size even after increasing the total volume (increasing the
amount of DNA).
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Figure 7: Obtaining Fragments from the Entire Partial Digestion of the Genomic
DNA of P. syringae
Four different partial digestions. 10ug of each was run on a gel. Each reaction included
40 ug of genomic DNA, 10XSau3A1 buffer, 1, 1.25, 1.5, or 2 units of Sau3Al (lanes 2 to
5, respectively), and enough water to reach 100 uL. Lanes 1 and 6 contain 0.25 ug of a
1.0 kb DNA ladder (New England Biolabs, Beverly, MA).
After a large enough library size could not be obtained, a new method for insert
isolation was performed. Instead of purifying a 1-5kb range of fragments from a gel, the
entire partial digest was purified using Qiagen's PCR purification method. The partial
digestions spanned an average of -0.1 kb to -10 kb (Figure 7). After each partial digest
was purified, all four digests were combined as insert. These inserts were ligated into
pBluescript and E. coli DH1OB was transformed. Plate results showed there to be about
1,000 successful clones and only -50 (1/20th) colonies containing insert-less vector. This
is a 20 fold improvement over ligations consisting of gel-purified inserts.
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Figure 8: Determining Insert Sizes from Successful Clones
Twenty colonies were isolated and miniprepped. Each uncut and cut plasmid is shown.
The (B) lanes include uncut and cut plasmids from a single blue, insert-less, colony. The
(PC) lanes include uncut and cut pBluescript. The first lane of each half of the gels
contains 0.25 ug of a 1.0 kb DNA ladder (New England Biolabs, Beverly, MA). The 3 kb
mark (size of pBluescript) on ladder is indicated in order to show where vector, without
insert, should be.
Each set of two lanes, corresponding to each colony number or type, includes
uncut and cut plasmid (Figure 8). Out of twenty colonies checked, seventeen appeared to
be successful clones (unless fragments from colonies 10, 16, and 18 were just too small
to detect). There is a wide range of insert sizes. As an example, set 3 (corresponding to
colony #3) contains uncut and cut plasmid in its first and second lane, respectively.
According to the lane that includes the digest, the fragment size is -7 kb. Clone #4
contained an insert that was too small (less than 0.5 kb). Since uronate dehydrogenase is
estimated to be 1,300 bp, this fragment would have a low chance of having this enzyme's
activity. Furthermore, inserts that are too large may not express fully unless their
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promoters are included inside the fragment itself. Sets 5, 6, 7, 9, 11, 14, 17, and 20
contained fragments of practical size. Therefore, 8/20 clones have a chance of exhibiting
uronate dehydrogenase activity. According to these results, for my library size of 1,000,
and out of 950 successful clones, it is estimated that 380 colonies could have uronate
dehydrogenase activity. The current library size is, therefore, about 380. The plan is to
increase the volume 10 fold. Previous experience with ethanol precipitation showed a 100
fold increase in colonies when a 10 fold volume increase of ligation is performed (data
not shown). Future work will include optimizing ligation volume in order to ensure there
is a 100 fold increase in library size.
4. Conclusions and Future Directions
DH1OB cells were grown in varying concentrations of glucaric acid in order to
test whether glucaric acid, once produced by cells, is toxic to them. Then, glucose uptake
was analyzed in the presence of glucaric acid in order to ensure maximum substrate
utilization once glucaric acid is produced. The vector for the library was chosen and
tested on glucose, glucaric acid, and glucuronic acid in order to verify that the screening
method will work. Finally, steps have been made in order to optimize library size in order
to express the final step of the benchmark pathway in E. coli.
According to the results, glucaric acid is not toxic to DH1OB cells. Specific
growth rates were determined for cells grown in 22 mM glucose and increasing
concentrations of glucaric acid. The values were very similar, regardless of the
concentration of glucaric acid (up to 40 mM) cells were grown in. Furthermore, glucaric
acid does not affect glucose uptake and so substrate utilization would not be hindered
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either. This was shown by measuring the concentration of glucose in the media as cells
were grown in varying amounts of glucaric acid (with an initial concentration of 22 mM
glucose in each culture). There was no apparent difference in glucose concentrations, at
any time point, regardless of the amount of glucaric acid present in the media.
The screening method was based on selecting for cells that can grow on
glucuronic acid plates. This was dependent on whether E. coli strains can grow on
glucaric acid and not on glucuronic acid. Then, because of the function of uronate
dehydrogenase, once cells contain this enzyme (after expressing fragments obtained from
the partial digestion), they will be able to grow on glucuronic acid - converting
glucuronic acid to glucaric acid, which can then be converted to biomass. DH1OB cells
harbored the ability to grow on glucaric acid and not on glucuronic acid plates. Unlike
DH1OB-pGEM3Z, DH1OB-pBluescript was also clearly able to grow on glucaric acid
and not on glucuronic acid. Furthermore, the maximum number of colonies was able to
grow on glucaric acid as compared to the number of colonies on LB and glucose plates.
This would, therefore, maximize the number of clones tested on glucuronic acid plates.
From these results, pBluescript is the vector of choice. The library is now being
constructed and optimized in order to express the final step of the pathway and select for
cells that contain uronate dehydrogenase activity.
It was evident that inserts purified from a gel resulted in lower library size than
those obtained straight from the partial digestion (using the PCR purification method).
Steps are now being taken in order to obtain the necessary number of successful clones.
Then, cells will be transformed and spread on glucuronic acid plates. Colonies that grow
will be further analyzed for their ability to convert glucuronic acid to glucaric acid. Then,
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protein will be isolated and tested in vitro for uronate dehydrogenase activity (ability to
produce NADH and glucaric acid). The HPLC (and a proposed boronic acid gel) will be
used in order to identify, quantify, and purify the glucaric acid that is produced.
Future work will also include isolating the enzymes necessary in order to
complete the other steps of the benchmark pathway. An assay for each reaction step will
be required in order to prove that the enzyme was successfully isolated from the host
organism and functions properly in E. col Once the entire pathway is expressed and
glucaric acid is produced, designed pathways using retro-biosynthesis will then be
expressed. The ease of design, expression, and ability to produce glucaric acid will then
be assessed by comparing it to the methods taken in designing and expressing the
benchmark pathway.
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